Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: Association with postoperative cardiac dysfunction and 1-year mortality*
Authors:
- Clarisse BerroetaCBClarisse Berroeta
- Catherine ReynaudCRCatherine Reynaud
- Gabriel BaronGBGabriel Baron
- Isabelle PoirierIPIsabelle Poirier
- Jean-Marie DesmontsJDJean-Marie Desmonts
- Bernard IungBIBernard Iung
- Monique DehouxMDMonique Dehoux
- Ivan PhilipIPIvan Philip
- Joëlle BénessianoJBJoëlle Bénessiano
- 1 April 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 34 (4) , 995-1000
Abstract
The purpose of the present study was to evaluate the prognostic implications of perioperative B-type natriuretic peptide (BNP) and cardiac troponin I concentrations in patients undergoing cardiopulmonary bypass for cardiac surgery. Prospective observational study. Biochemistry laboratory and surgical care unit in a university hospital. A total of 92 consecutive patients undergoing elective coronary artery (43 patients) or valve surgery (49 patients). None. BNP and cardiac troponin I concentrations were measured before surgery (day 0), and at day 1 after surgery. Postoperative cardiac dysfunction was defined as low cardiac output or hemodynamic instability requiring inotropic support for >24 hrs or congestive heart failure until day 5. One-year survival was also evaluated. Univariate and multivariate analyses were performed. An important BNP secretion was systematically observed after cardiac surgery. Independent predictors of cardiac dysfunction were preoperative New York Health Association class and BNP and cardiac troponin I concentrations measured at day 1. Patients with an elevation of both markers have a 12-fold increased risk of postoperative heart failure. The use of both markers in combination predicted better postoperative heart failure than each one separately. Age, low preoperative left ventricular ejection fraction, and elevated BNP at day 1 (>352 pg/mL) were associated with an increased mortality rate at 1 yr. In multivariate analysis, only left ventricular ejection fraction was significantly associated with 1-yr survival. Postoperative plasma BNP and cardiac troponin I levels are independent predictors of postoperative cardiac dysfunction after cardiac surgery. Simultaneous measurement of BNP and cardiac troponin I improve the risk assessment of postoperative cardiac dysfunction. However, the association between BNP levels and 1-yr outcome was no longer significant after adjustment on left ventricular ejection fraction.Keywords
This publication has 19 references indexed in Scilit:
- Utility of B-type natriuretic peptide in predicting the level of peri- and postoperative cardiovascular support required after coronary artery bypass grafting*Critical Care Medicine, 2005
- Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgeryJACC, 2004
- A-Type and B-Type Natriuretic Peptides in Cardiac Surgical ProceduresAnesthesia & Analgesia, 2004
- N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary SyndromesCirculation, 2002
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart FailureCirculation, 2002
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care settingJACC, 2001
- Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgerySurgery Today, 1998
- Augmented release of brain natriuretic peptide during reperfusion of the human heart after cardioplegic cardiac arrestClinica Chimica Acta, 1997
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.Circulation, 1993